ID   TRUA_HUMAN              Reviewed;         427 AA.
AC   Q9Y606; A8K877; B3KQC1; Q8WYT2; Q9BU44;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 3.
DT   12-APR-2017, entry version 158.
DE   RecName: Full=tRNA pseudouridine synthase A, mitochondrial;
DE            EC=5.4.99.12;
DE   AltName: Full=tRNA pseudouridine(38-40) synthase;
DE   AltName: Full=tRNA pseudouridylate synthase I;
DE   AltName: Full=tRNA-uridine isomerase I;
DE   Flags: Precursor;
GN   Name=PUS1; ORFNames=PP8985;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Mammary gland, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 63-427.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10094309; DOI=10.1017/S1355838299981591;
RA   Chen J., Patton J.R.;
RT   "Cloning and characterization of a mammalian pseudouridine synthase.";
RL   RNA 5:409-419(1999).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420 AND THR-426, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   SUBCELLULAR LOCATION (ISOFORMS 1 AND 2).
RX   PubMed=17056637; DOI=10.1136/jmg.2006.045252;
RA   Fernandez-Vizarra E., Berardinelli A., Valente L., Tiranti V.,
RA   Zeviani M.;
RT   "Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two
RT   brothers affected by myopathy, lactic acidosis and sideroblastic
RT   anaemia (MLASA).";
RL   J. Med. Genet. 44:173-180(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420 AND THR-426, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-415; SER-420 AND
RP   THR-426, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420 AND THR-426, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420 AND THR-426, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420 AND THR-426, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   VARIANT MLASA1 TRP-144, AND TISSUE SPECIFICITY.
RX   PubMed=15108122; DOI=10.1086/421530;
RA   Bykhovskaya Y., Casas K., Mengesha E., Inbal A., Fischel-Ghodsian N.;
RT   "Missense mutation in pseudouridine synthase 1 (PUS1) causes
RT   mitochondrial myopathy and sideroblastic anemia (MLASA).";
RL   Am. J. Hum. Genet. 74:1303-1308(2004).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-133.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [18]
RP   VARIANT MLASA1 TRP-144.
RX   PubMed=19731322; DOI=10.1002/pbc.22244;
RA   Bergmann A.K., Campagna D.R., McLoughlin E.M., Agarwal S.,
RA   Fleming M.D., Bottomley S.S., Neufeld E.J.;
RT   "Systematic molecular genetic analysis of congenital sideroblastic
RT   anemia: evidence for genetic heterogeneity and identification of novel
RT   mutations.";
RL   Pediatr. Blood Cancer 54:273-278(2010).
CC   -!- FUNCTION: Converts specific uridines to PSI in a number of tRNA
CC       substrates. Acts on positions 27/28 in the anticodon stem and also
CC       positions 34 and 36 in the anticodon of an intron containing tRNA.
CC       Involved in regulation of nuclear receptor activity possibly
CC       through pseudouridylation of SRA1 RNA (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: tRNA uridine(38-40) = tRNA pseudouridine(38-
CC       40).
CC   -!- SUBUNIT: Forms a complex with RARG and the SRA1 RNA in the
CC       nucleus. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Mitochondrion
CC       {ECO:0000269|PubMed:17056637}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Nucleus
CC       {ECO:0000269|PubMed:17056637}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y606-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y606-2; Sequence=VSP_020116;
CC   -!- TISSUE SPECIFICITY: Widely expressed. High levels of expression
CC       found in brain and skeletal muscle. {ECO:0000269|PubMed:15108122}.
CC   -!- DISEASE: Myopathy with lactic acidosis and sideroblastic anemia 1
CC       (MLASA1) [MIM:600462]: A rare oxidative phosphorylation disorder
CC       specific to skeletal muscle and bone marrow. Affected individuals
CC       manifest progressive muscle weakness, exercise intolerance, lactic
CC       acidosis, sideroblastic anemia and delayed growth.
CC       {ECO:0000269|PubMed:15108122, ECO:0000269|PubMed:16959974,
CC       ECO:0000269|PubMed:19731322}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the tRNA pseudouridine synthase TruA
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF318369; AAL55876.1; -; mRNA.
DR   EMBL; AK074659; BAG51983.1; -; mRNA.
DR   EMBL; AK292242; BAF84931.1; -; mRNA.
DR   EMBL; BC002901; AAH02901.1; -; mRNA.
DR   EMBL; BC009505; AAH09505.2; -; mRNA.
DR   EMBL; BC019320; AAH19320.2; -; mRNA.
DR   EMBL; AF116238; AAD21042.1; -; mRNA.
DR   CCDS; CCDS31928.1; -. [Q9Y606-2]
DR   CCDS; CCDS9275.2; -. [Q9Y606-1]
DR   RefSeq; NP_001002019.1; NM_001002019.2. [Q9Y606-2]
DR   RefSeq; NP_001002020.1; NM_001002020.2. [Q9Y606-2]
DR   RefSeq; NP_079491.2; NM_025215.5. [Q9Y606-1]
DR   UniGene; Hs.592004; -.
DR   PDB; 4IQM; X-ray; 1.80 A; A=79-408.
DR   PDB; 4ITS; X-ray; 1.85 A; A=79-408.
DR   PDB; 4J37; X-ray; 1.75 A; A=79-408.
DR   PDB; 4NZ6; X-ray; 2.00 A; A/B=83-394.
DR   PDB; 4NZ7; X-ray; 2.70 A; A=83-394.
DR   PDBsum; 4IQM; -.
DR   PDBsum; 4ITS; -.
DR   PDBsum; 4J37; -.
DR   PDBsum; 4NZ6; -.
DR   PDBsum; 4NZ7; -.
DR   ProteinModelPortal; Q9Y606; -.
DR   SMR; Q9Y606; -.
DR   BioGrid; 123236; 48.
DR   IntAct; Q9Y606; 4.
DR   MINT; MINT-2823994; -.
DR   STRING; 9606.ENSP00000365837; -.
DR   iPTMnet; Q9Y606; -.
DR   PhosphoSitePlus; Q9Y606; -.
DR   SwissPalm; Q9Y606; -.
DR   BioMuta; PUS1; -.
DR   DMDM; 114152895; -.
DR   EPD; Q9Y606; -.
DR   PaxDb; Q9Y606; -.
DR   PeptideAtlas; Q9Y606; -.
DR   PRIDE; Q9Y606; -.
DR   DNASU; 80324; -.
DR   Ensembl; ENST00000376649; ENSP00000365837; ENSG00000177192. [Q9Y606-1]
DR   Ensembl; ENST00000443358; ENSP00000392451; ENSG00000177192. [Q9Y606-2]
DR   GeneID; 80324; -.
DR   KEGG; hsa:80324; -.
DR   UCSC; uc001ujf.4; human. [Q9Y606-1]
DR   CTD; 80324; -.
DR   DisGeNET; 80324; -.
DR   GeneCards; PUS1; -.
DR   HGNC; HGNC:15508; PUS1.
DR   HPA; HPA051636; -.
DR   HPA; HPA057593; -.
DR   MalaCards; PUS1; -.
DR   MIM; 600462; phenotype.
DR   MIM; 608109; gene.
DR   neXtProt; NX_Q9Y606; -.
DR   OpenTargets; ENSG00000177192; -.
DR   Orphanet; 2598; Mitochondrial myopathy and sideroblastic anemia.
DR   PharmGKB; PA34047; -.
DR   eggNOG; KOG2553; Eukaryota.
DR   eggNOG; COG0101; LUCA.
DR   GeneTree; ENSGT00510000047706; -.
DR   HOGENOM; HOG000031229; -.
DR   HOVERGEN; HBG000489; -.
DR   InParanoid; Q9Y606; -.
DR   KO; K06173; -.
DR   OMA; KNKCDAR; -.
DR   OrthoDB; EOG091G0CIE; -.
DR   PhylomeDB; Q9Y606; -.
DR   TreeFam; TF314367; -.
DR   BRENDA; 5.4.99.B22; 2681.
DR   Reactome; R-HSA-6782315; tRNA modification in the nucleus and cytosol.
DR   Reactome; R-HSA-6787450; tRNA modification in the mitochondrion.
DR   ChiTaRS; PUS1; human.
DR   GeneWiki; PUS1; -.
DR   GenomeRNAi; 80324; -.
DR   PRO; PR:Q9Y606; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000177192; -.
DR   CleanEx; HS_PUS1; -.
DR   ExpressionAtlas; Q9Y606; baseline and differential.
DR   Genevisible; Q9Y606; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0009982; F:pseudouridine synthase activity; EXP:Reactome.
DR   GO; GO:0004730; F:pseudouridylate synthase activity; NAS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0070902; P:mitochondrial tRNA pseudouridine synthesis; TAS:Reactome.
DR   GO; GO:1990481; P:mRNA pseudouridine synthesis; IBA:GO_Central.
DR   GO; GO:0031119; P:tRNA pseudouridine synthesis; IBA:GO_Central.
DR   Gene3D; 3.30.70.660; -; 1.
DR   InterPro; IPR020103; PsdUridine_synth_cat_dom.
DR   InterPro; IPR001406; PsdUridine_synth_TruA.
DR   InterPro; IPR020097; PsdUridine_synth_TruA_a/b_dom.
DR   InterPro; IPR020095; PsdUridine_synth_TruA_C.
DR   PANTHER; PTHR11142; PTHR11142; 1.
DR   Pfam; PF01416; PseudoU_synth_1; 1.
DR   SUPFAM; SSF55120; SSF55120; 1.
DR   TIGRFAMs; TIGR00071; hisT_truA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Disease mutation; Isomerase; Mitochondrion; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transit peptide; tRNA processing.
FT   TRANSIT       1      ?       Mitochondrion. {ECO:0000255}.
FT   CHAIN         ?    427       tRNA pseudouridine synthase A,
FT                                mitochondrial.
FT                                /FTId=PRO_0000057517.
FT   ACT_SITE    146    146       Nucleophile. {ECO:0000250}.
FT   BINDING     201    201       Substrate. {ECO:0000250}.
FT   MOD_RES     415    415       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     420    420       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     426    426       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1     28       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020116.
FT   VARIANT     133    133       D -> N (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs76655496).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036447.
FT   VARIANT     144    144       R -> W (in MLASA1; dbSNP:rs104894371).
FT                                {ECO:0000269|PubMed:15108122,
FT                                ECO:0000269|PubMed:19731322}.
FT                                /FTId=VAR_021788.
FT   CONFLICT     70     70       K -> R (in Ref. 4; AAD21042).
FT                                {ECO:0000305}.
FT   STRAND       83     92       {ECO:0000244|PDB:4J37}.
FT   STRAND       99    101       {ECO:0000244|PDB:4IQM}.
FT   HELIX       112    122       {ECO:0000244|PDB:4J37}.
FT   HELIX       128    132       {ECO:0000244|PDB:4J37}.
FT   HELIX       134    137       {ECO:0000244|PDB:4J37}.
FT   STRAND      140    142       {ECO:0000244|PDB:4J37}.
FT   STRAND      150    161       {ECO:0000244|PDB:4J37}.
FT   HELIX       166    172       {ECO:0000244|PDB:4J37}.
FT   STRAND      178    186       {ECO:0000244|PDB:4J37}.
FT   HELIX       192    195       {ECO:0000244|PDB:4IQM}.
FT   STRAND      198    206       {ECO:0000244|PDB:4J37}.
FT   HELIX       207    210       {ECO:0000244|PDB:4J37}.
FT   TURN        213    215       {ECO:0000244|PDB:4J37}.
FT   HELIX       226    238       {ECO:0000244|PDB:4J37}.
FT   STRAND      241    244       {ECO:0000244|PDB:4J37}.
FT   HELIX       246    248       {ECO:0000244|PDB:4J37}.
FT   STRAND      249    251       {ECO:0000244|PDB:4IQM}.
FT   STRAND      252    254       {ECO:0000244|PDB:4J37}.
FT   HELIX       257    259       {ECO:0000244|PDB:4IQM}.
FT   STRAND      260    268       {ECO:0000244|PDB:4J37}.
FT   STRAND      272    274       {ECO:0000244|PDB:4J37}.
FT   STRAND      277    288       {ECO:0000244|PDB:4J37}.
FT   HELIX       293    305       {ECO:0000244|PDB:4J37}.
FT   HELIX       313    317       {ECO:0000244|PDB:4J37}.
FT   STRAND      319    321       {ECO:0000244|PDB:4J37}.
FT   STRAND      333    338       {ECO:0000244|PDB:4J37}.
FT   HELIX       341    344       {ECO:0000244|PDB:4IQM}.
FT   HELIX       359    361       {ECO:0000244|PDB:4J37}.
FT   HELIX       362    371       {ECO:0000244|PDB:4J37}.
FT   HELIX       373    384       {ECO:0000244|PDB:4J37}.
FT   HELIX       386    391       {ECO:0000244|PDB:4J37}.
FT   HELIX       392    396       {ECO:0000244|PDB:4J37}.
FT   HELIX       401    404       {ECO:0000244|PDB:4IQM}.
SQ   SEQUENCE   427 AA;  47470 MW;  ACE9FA6AE0F178BA CRC64;
     MGLQLRALLG AFGRWTLRLG PRPSCSPRMA GNAEPPPAGA ACPQDRRSCS GRAGGDRVWE
     DGEHPAKKLK SGGDEERREK PPKRKIVLLM AYSGKGYHGM QRNVGSSQFK TIEDDLVSAL
     VRSGCIPENH GEDMRKMSFQ RCARTDKGVS AAGQVVSLKV WLIDDILEKI NSHLPSHIRI
     LGLKRVTGGF NSKNRCDART YCYLLPTFAF AHKDRDVQDE TYRLSAETLQ QVNRLLACYK
     GTHNFHNFTS QKGPQDPSAC RYILEMYCEE PFVREGLEFA VIRVKGQSFM MHQIRKMVGL
     VVAIVKGYAP ESVLERSWGT EKVDVPKAPG LGLVLERVHF EKYNQRFGND GLHEPLDWAQ
     EEGKVAAFKE EHIYPTIIGT ERDERSMAQW LSTLPIHNFS ATALTAGGTG AKVPSPLEGS
     EGDGDTD
//
